IBDEI17J ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20167,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,20168,0)
 ;;=G20.^^94^936^24
 ;;^UTILITY(U,$J,358.3,20168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20168,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20168,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,20168,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,20169,0)
 ;;=G20.^^94^936^25
 ;;^UTILITY(U,$J,358.3,20169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20169,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20169,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,20169,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,20170,0)
 ;;=G31.01^^94^936^26
 ;;^UTILITY(U,$J,358.3,20170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20170,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,20170,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,20170,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,20171,0)
 ;;=G23.1^^94^936^28
 ;;^UTILITY(U,$J,358.3,20171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20171,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,20171,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,20171,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,20172,0)
 ;;=Z79.2^^94^937^1
 ;;^UTILITY(U,$J,358.3,20172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20172,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,20172,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,20172,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,20173,0)
 ;;=Z79.01^^94^937^2
 ;;^UTILITY(U,$J,358.3,20173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20173,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,20173,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,20173,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,20174,0)
 ;;=Z79.02^^94^937^3
 ;;^UTILITY(U,$J,358.3,20174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20174,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,20174,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,20174,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,20175,0)
 ;;=Z79.82^^94^937^4
 ;;^UTILITY(U,$J,358.3,20175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20175,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,20175,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,20175,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,20176,0)
 ;;=Z79.4^^94^937^5
 ;;^UTILITY(U,$J,358.3,20176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20176,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,20176,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,20176,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,20177,0)
 ;;=Z79.1^^94^937^7
 ;;^UTILITY(U,$J,358.3,20177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20177,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,20177,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,20177,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,20178,0)
 ;;=Z79.891^^94^937^8
 ;;^UTILITY(U,$J,358.3,20178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20178,1,3,0)
 ;;=3^Opiate Analgesic
 ;;^UTILITY(U,$J,358.3,20178,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,20178,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,20179,0)
 ;;=Z79.51^^94^937^9
 ;;^UTILITY(U,$J,358.3,20179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20179,1,3,0)
 ;;=3^Steroids-Inhaled
 ;;^UTILITY(U,$J,358.3,20179,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,20179,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,20180,0)
 ;;=Z79.52^^94^937^10
 ;;^UTILITY(U,$J,358.3,20180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20180,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,20180,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,20180,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,20181,0)
 ;;=Z79.899^^94^937^6
 ;;^UTILITY(U,$J,358.3,20181,1,0)
 ;;=^358.31IA^4^2
